Stockreport

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains [Yahoo! Finance]

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF OPKO Health, Inc. 's OPK company, ModeX Therapeutics Inc., announced the dosing of the first participant in the Phase I study (NCT06655324) of an Epstein-Barr virus (EB [Read more]